A medical diagnostics company, ISN Medical, has launched a campaign to screen one million newborns in Nigeria for congenital and inherited conditions from 2026 to 2030, aimed at improving early detection, diagnosis, intervention, treatment and child health outcomes in Nigeria and Africa at large.
The initiative, unveiled in Lagos on Friday in partnership with global healthcare innovation company Revvity, seeks to expand access to advanced newborn screening technologies, strengthen local healthcare capacity and improve diagnostic services across Nigeria and Africa.
Speaking at the launch, the Managing Director of ISN Medical, Felix Ofungwu, described the initiative as a milestone in the company’s commitment to transforming healthcare delivery through innovation, accessibility and improved diagnostics.
In a statement sent to PUNCH Healthwise, Ofungwu said the programme was designed to improve the early detection of congenital and inherited conditions, enabling timely interventions that could significantly improve health outcomes for newborns.
“Today marks a significant
This post was originally published on this site.
